FATTY LIVER – often co-exists with other liver diseases

In The “Medicine Today” Journal February 2003, Volume 4, Number 2, the article titled “fatty liver disease – the next epidemic?” was worth reading. Surprisingly in the United States it has been estimated that fatty liver affects 15 to 20% of the general population and is higher in obese individuals. While the true prevalence of fatty liver in Australia remains to be determined, it is frequently found as an incidental abnormality in patients. Non-alcoholic fatty liver disease (NAFLD) is often seen in patients who are overweight, who have insulin resistance or type 2 diabetes. NAFLD comprises a wide spectrum of liver damage ranging from simple steatosis to steatohepatitis, fibrosis and cirrhosis. There is no recognised treatment for NAFLD and management consists of weight loss through a healthy diet and reducing insulin resistance. The eating plan in the book: I Can't Lose Weight!...And I Don't Know Why! is specifically designed to reverse insulin resistance and fatty liver disease.